30 Hot Line studies at #ESCCongress2023 and 7 are presented by women. The first female presenter is Lene Nyhus Andreasen on the OCTOBER Trial in Hot Line 4 Sunday morning at 8:52. OCT or angio-guided bifurcation PCI. Women As One Mamas A. Mamas #ILookLikeACardiologist #WomenInCardiology

Tune in at room Lisbon at 11:28 to see Ashkan Eftekhari present our late breaking meta-analysis of 5-year outcome in the DEFINE FLAIR and iFR-SWEDEHEART trials 🤙🔥 Department of Cardiology Research AUH Dansk Cardiologisk Selskab (DCS) Evald Høj Christiansen Jelmer Westra Thomas Engstrøm

Very proud of this publication. Thanks to Lene Nyhus Andreasen Omeed Neghabat Evald Høj Christiansen Dr Peter O'Kane jcspratt Simone Biscaglia FRANCESCO BURZOTTA Jacob Odenstedt Thue Olsen Department of Cardiology Research AUH Aarhus Uni.hospital Aarhus Universitet

Happy to see so many moderated abstracts on #CTO treatment at #TCT2023! ⁉️ However, we need proper randomized data! Worrying that J Aaron Grantham JAG fears that CTO PCI is going to be downgraded in guidelines 💎 ISCHEMIA CTO is ongoing and we have enrolled 2/3 of the symptomatic arm!

💎 New The Dan-NICAD trials trial substudy by Jelmer Westra and PI Evald Høj Christiansen in JACC Journals 🎓 The diagnostic performance of QFR and FFR is similar but modest using 82rb-PET myocardial perfusion Imaging as a reference link: jacc.org/doi/abs/10.101… #CardioTwitter

Strange not mentioning Dr. Henning Rud Andersen, the inventor of TAVI, at all in such a piece. Read his inspirationsl story here: frontiersin.org/articles/10.33… EuroIntervention

📕Off press Circulation: Cardiovascular Imaging. Impact of Absolute Myocardial Blood Flow Quantification on the Diagnostic Performance of PET-Based Perfusion Scans Using 82Rubidium. ahajournals.org/doi/10.1161/CI…

Congratulations to our PhD student Emil Nielsen Holck having the best Award-Winning Abstract presentation at #CTO2024 New York Emmanouil Brilakis Margaret McEntegart Lars Jakobsen Department of Cardiology Research AUH Aarhus Uni.hospital LAD CTO unopened is high risk!

Way to go! 🤟

Out in Circle Cardiovascular Imaging: Myocardial Blood Flow by Magnetic Resonance in Patients With Suspected Coronary Stenosis: Comparison to PET and Invasive Physiology. ahajournals.org/doi/pdf/10.116…

#CoronaryPhysiology Clinical Likelihood Prediction of Hemodynamically Obstructive Coronary Artery Disease in Patients With Stable Chest Pain 👇 sciencedirect.com/science/articl… 👋 Laust Dupont Rasmussen Jelmer Westra Niels R. Holm Evald Høj Christiansen Ashkan Eftekhari #DanNICAD NCT02264717

🗣️ Excited to share our new study revealing the hemodynamic benefits of ketone ester treatment in patients with #HFpEF! 🫀 Circulation ahajournals.org/doi/10.1161/CI… Kristoffer Berg Hansen Kristian Christensen Bertil Ladefoged @bborlaugmd Mads J Andersen

Primary endpoint of the The FAVOR III trial on QFR vs. FFR is presented on 30. October at #TCT2024 #qfr #randomizedtrial #cardiotwitter Birgitte Krogsgaard Evald Høj Christiansen Javier Escaned Gianluca Campo Dr Koltowski Greta Žiubrytė, MD, PhD candidate Martin Sejr-Hansen Ignacio J. Amat Barbara Stähli HernánMR Luigi Di Serafino

Dan-NICAD study shows in pts with stable new-onset chest pain and moderate coronary stenoses of unclear functional significance, low microvascular resistance reserve (MRR) is associated with freedom of angina beyond CFR and FFR #ESCCongress

Microvascular resistance reserve (MRR) associated with rates of angina after revascularization in pts with moderate coronary stenosis beyond CRF or FFR. Watch Dr. Laust Dupont Rasmussen present results of Dan-NICAD study presented at #ESCCongress

What a day yesterday 🔥. I have finally defended my PhD at Aarhus Universitet about #CTOPCI ! Thanks to colleagues, friends and family who have supported me me through the years. A special thanks to supervisors and the assessment committee for making the day perfect 🫀

Congratulations! Great pleasure to follow your journey! Many more moments to come!

TCTMD Interview with Birgitte Krogsgaard William Fearon and Mamas A. Mamas on the The FAVOR III trial - LBT presentation #TCT2024 Wednesday at 11:47 EST - Details in the simultaneous publication #coronaryphysiology #randomizedtrial #cardiotwitter

1/x #QFR did not meet non-inferiority to FFR in the The FAVOR III trial Europe presented by Birgitte Krogsgaard The 1-year primary EP of death, MI, and unplanned revasc was 6.7% vs 4.2% in favour of FFR. 21% more study-lesions were treated- and 27% more stents were implanted with QFR due

#IntravascularImaging #OCT #VFR ILUMIEN-IV substudy: OCT-Based Post-PCI Physiology to Predict Clinical Outcomes 👇 jacc.org/doi/10.1016/j.… EDITORIAL 👇 jacc.org/doi/10.1016/j.… 👋Allen Jeremias